For decades, access to prescription drugs has been limited by profit-seeking PBMs who drive up costs for Illinoisans and force pharmacies to close. We took bipartisan action this session to protect consumers and save our local pharmacies from being driven out of our communities.

Pharmacy benefit managers have helped drive local pharmacies out of business and increased the costs of your prescriptions. I'm proud to say that's no longer the case here — we’re putting an end to their predatory practices. The nation should follow suit.chicagobusiness.com/health-care/co…

Top 5 Physician Takeaways from the CMS 2026 Analysis: 1. “The Writing is on the Wall for Independent Practice” The 0.5% payment differential between APM and non-APM physicians, combined with the 2.5% efficiency cuts, makes it mathematically clear that CMS is systematically

Thank you NCOIL for inviting NCPA to share perspective and potential concerns about Prescription Drug Affordability Boards and their use of Upper Payment Limits. A key message was how pharmacies are aligned with patients on lowering their drug costs.

We're lowering the cost of your prescriptions and protecting Illinoisans at the same time.

As more Rite Aids shut their doors across WNY, brace yourself - another major healthcare shakeup is coming in the next few weeks. An announcement was made by the CEO at a company-wide meeting late last week. Once again, you can thank Obamacare and Governor Kathy Hochul.

The release of The Sunlight Report means the public finally has some transparency into UnitedHealth Group’s vast, sprawling network of nearly 2,700 subsidiaries. But what does it mean for patients in our health care system? 🧵 #SunlightUNH

Listen to the full conversation here: kslnewsradio.com/utah/pharmacis…

#Macro Chart of the Day (Day 14) transitions to a new theme... #Medicaid! Figured we should all learn about this program that covers nearly 30% of all Americans before it gets meaningfully cut (thanks to the #onebigbeautifulbill after the 2026 mid-term elections). Today's chart

Recently, #PBMs have started to adopt their own “house brand” logic to pharmaceuticals by creating offshore subsidiaries that buy FDA-approved products in bulk, wrap them in exclusive labels, and then prefer those products on their own formularies. | 46brooklyn Research

Decades after retreating from their former marriages, PBMs are blending their DNA with drug companies once again, this time through private labelling. Here's what it means for the costs of medicines. Our latest: 46brooklyn.com/research/welco…

Has your member of Congress cosponsored H.R. 4317?? ▶️Take a look at the list of cosponsors here: congress.gov/bill/119th-con… ▶️Ask your representative to take action here: ncpa.org/legislative-ac…

A new study finds that when hospitals acquire physician practices, those doctors raise their prices by 15% within 2 years compared to independent peers. Healthcare M&A should be about integration and efficiencies. Too often, it's just about leveraging higher reimbursements rates.

Bottom line: • PBMs profit from price inflation, not price reduction • Real-world PBM-free models already show significant savings • Transparent, fixed-fee models create aligned incentives between payers, pharmacies, and patients Reform is not about eliminating value—it’s

Disintermediating PBM middlemen would save Americans $100b a year says USC research. They nailed it academic.oup.com/healthaffairss…

wgrz.com/article/money/…

Meet Kurt Proctor, NCPA’s senior VP of strategic initiatives and president of the NCPA Innovation Center. Kurt’s journey began in his family’s corner drugstore in Cass City, Mich. — a small-town start that sparked a lifelong commitment to independent pharmacy. Since joining

We disagree. "Health systems are already enforcing physician referrals within the entity with which physicians have a financial relationship—the very activity the Stark Law prohibits for self-employed physicians... The Stark Law tilts the playing field in favor of large health

One of the goals with this documentary is to reinforce that the issues within pharmacy are nationwide. The root cause isn’t “bad management” by individual pharmacy teams. There are underlying systemic issues that have led to where we are today.